Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
[Dilip Davda] CHL is a diagnostic service provider in the northern region. It covers pathological and radio-logical testing services under one roof. The company marked steady growth in its top and bottom lines for the reported periods. The boost in bottom lines from FY24 onwards is attributed to break-even by its new centers established in the last three years. Based on its recent financial performances, the issue appears lucratively priced. The management is confident for maintaining the margins earned since FY24 onwards. Investors may park funds for medium to long term. Read detail review...
Chandan Healthcare Limited peer comparison with similar listed entities. (As on March 28, 2024)
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|---|---|---|---|---|---|---|
| Chandan Healthcare Limited | 8.14 | 8.14 | 20.58 | 39.54 | Consolidated | ||
| Vijaya Diagnostic Centre Limited | 11.62 | 11.59 | 64.21 | 87.75 | 19.91 | 9.94 | Consolidated |
| Dr. Lal Pathlabs Ltd | 46.25 | 46.18 | 221.61 | 62.34 | 20.61 | 10.24 | Consolidated |
| Metropolis Healthcare Ltd | 24.95 | 24.87 | 214.01 | 72.18 | 12.33 | 8.05 | Consolidated |
Source:
All the financial information for listed industry peers mentioned above is on a consolidated basis (If applicable) sourced from the Annual Reports of the peer company uploaded on the NSE website for the year ended March 31, 2024.
Notes:
Chandan Healthcare IPO Reviews, analysis and views by popular members. Read Chandan Healthcare Ltd. IPO reviews by retail investors to find recommended ipo to buy.
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
Note:
Useful Articles
RHP